Optio RX

What Optio RX does

OptioRx LLC is a privately held U.S. specialty compounding pharmacy operator founded in 2018 and headquartered in Palm Beach Gardens, Florida, with additional operational presence in Oak Brook, Illinois. The company produces customized pharmaceutical products under both 503A (patient-specific) and 503B (office-use) regulatory frameworks across therapy areas including bioidentical hormone replacement therapy, fertility medications, wellness compounding, hospice pharmacy, specialty care (dermatology, neurology, podiatry, ophthalmology, women's health), Low Dose Naltrexone, and animal-free formulations. OptioRx runs a hub-and-spoke operating model: a centralized Customer Service HUB in the Chicago area processes all prescriptions and ships directly to patients nationwide, supported by seven compounding fulfillment pharmacies located in California, Texas, Illinois, Ohio, and Florida, with licensing in most U.S. states. The company is PCAB-accredited, USP-compliant, HIPAA-compliant, and operates under FDA and state board of pharmacy oversight.

OptioRx generates revenue on a per-prescription basis through compounded medication dispensing, specialty care pharmacy fulfillment, and centralized HUB processing services that include patient consultation, formulation preparation, quality assurance, fulfillment, insurance billing, and pharmacy benefit manager coordination. Its go-to-market is hybrid: a dedicated sales team (888-241-2948) registers and onboards prescribers and clinics (enterprise field sales motion), while a customer service HUB (888-897-3304), the RxLocal mobile app (iOS/Android), an online prescription portal at patient.rxlocal.com, and seven brick-and-mortar affiliated pharmacy locations serve patients directly (direct-to-consumer and self-serve channels). Marketing leverages an educational blog, social media presence on Facebook, LinkedIn, Instagram, and Pinterest, and inbound provider inquiry funnels.

The technology stack is a compounding-pharmacy operations platform rather than a software product: the HUB functions as a central processing center staffed by dedicated technician teams, supported by RxLocal (provided by New Tech Systems) as the patient-facing mobile and desktop refill interface, an IT Hub in Northbrook for software, analytics, and engineering, and integrations with insurance billing and pharmacy benefit managers. OptioRx has secured $27.3 million in funding from Capitala Group (2018), employs 101–250 staff across clinical, operational, and technology functions, and discloses no external investors, private equity backing, or parent company beyond the founding team and management bench drawn from BodyLogicMD, Wells Pharmacy Network, Belmar Pharma Solutions, and other healthcare operators.

Name

Optio RX

Legal name

OptioRx LLC

Website

https://optiorx.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

101–250 employees

Short description

OptioRx is a privately held U.S. specialty compounding pharmacy operator that prepares and dispenses customized 503A and 503B medications across hormone therapy, fertility, wellness, hospice, and specialty care, serving individual patients and prescribing providers nationwide through a centralized HUB, seven fulfillment pharmacies, and the RxLocal patient platform.

Ownership category

akta.pro rank

Product category

Specialty Compounding Pharmacy Services

NAICS

Pharmacies and Drug Retailers (456110), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Prescription Pickup, Delivery & Refill Coordination (HSABALAC)

akta.pro secondary industries

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Injectables & Specialty Medication Support (e.g., insulin, biologics) (HSABALAG), Pharmacy & Health Essentials Delivery (CRAFAFAI)

Keywords

• Compounding pharmacy services
• Specialty pharmaceutical compounding
• Bioidentical hormone therapy
• Customized prescription medications
• Home infusion pharmacy

Headquarters

HQ city

Oak Brook

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Compounded Prescription Medications: OptioRx prepares and dispenses customized compounded medications for individual patients based on valid prescriptions. Services cover hormone therapy (BHRT), fertility medications, wellness compounding, hospice pharmacy, specialty care pharmacy, and Low Dose Naltrexone. Revenue is generated per prescription with both sterile and non-sterile formulations available.
2. Specialty Care Pharmacy Dispensing: Dispensing of hard-to-find medications for dermatology, neurology, podiatry, ophthalmology, and women's health specialties. Medications are shipped directly to patients or available for in-store pickup.
3. Prescription Processing Services: Revenue generated through processing prescriptions via the central HUB, including patient consultation, formulation preparation, quality assurance, and fulfillment. Patient payments, insurance billing, and pharmacy benefit manager coordination are part of the payment operations.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

OptioRx operates a national hub-and-spoke compounding pharmacy that prepares and dispenses customized pharmaceutical products for individual patients based on valid prescriptions. The company delivers both 503A (patient-specific) and 503B (office-use) compounded medications across therapy areas including hormone replacement therapy, fertility, wellness, hospice, and specialty care, with all prescriptions routed through a central processing HUB for home delivery or in-store pickup.

Product overview

OptioRx is a premier national compounding pharmacy operating as a single unified platform that provides customized pharmaceutical products through a hub-and-spoke distribution model. The core offering is customized compounding pharmacy services (both 503A and 503B) which produce personalized medications tailored to individual patient needs. These services span multiple therapy areas including Wellness Compounding, Hormone Compounding/BHRT, Fertility Medications, Animal-Free Compounding, Hospice Pharmacy, and Specialty Care Pharmacy. Supporting the compounding services are patient-facing tools including the RxLocal mobile app for prescription refills and the patient.rxlocal.com online portal. All prescriptions flow through The HUB, a central processing center, before direct home delivery nationwide or pickup at affiliated pharmacy locations across California, Texas, Illinois, Ohio, and Florida.

Differentiator

Problem solved

Functional benefit

Products and services

• Customized Compounding Pharmacy Premier national pharmacy providing customized pharmaceutical products tailored to individual patient needs, offering both 503A (patient-specific) and 503B (office-use) compounding services for healthcare providers and patients nationwide.
• Wellness Compounding

Quantifiable outcome

• Speed to therapy: centralized HUB processing enables faster prescription fulfillment with a dedicated team of technicians
• +2 more outcomes

Named customers4 records

Segments7 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• RxLocal (New Tech Systems)coreTechnology or IntegrationOptioRx utilizes the RxLocal platform as its primary digital patient interface for prescription refills, medication reminders, pharmacy locator, and support requests. The mobile app is available on iOS (App Store) and Android (Google Play Store). This partnership provides the technology infrastructure for OptioRx's self-serve and mobile patient engagement channels.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Fagron: Fagron is a global leader in pharmaceutical compounding, supplying APIs, excipients, and compounding services across more than 30 countries. It is comparable as a large, multi-national compounding platform with a broader product portfolio than OptioRx and competing for the same prescriber and pharmacy customer base.
• Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy dispenses specialty medications nationwide through retail and central-fill locations. It is comparable as a broad incumbent in specialty pharmacy that competes with OptioRx for some specialty dispensing and provider relationships, though with a much larger portfolio.

Direct peers

• Belmar Pharma Solutions: Belmar Pharma Solutions is a national 503A and 503B compounding pharmacy offering customized BHRT, veterinary, and integrative medicine preparations. It is a direct peer given overlapping 503A/503B services, BHRT focus, and prior employment overlap with OptioRx's CCO.
• Wells Pharmacy Network: Wells Pharmacy Network is a 503A and 503B compounding pharmacy serving anti-aging, wellness, and integrative medicine practices. It is a direct peer in both service mix and customer base, and the prior employer of OptioRx's CEO and CCO.
• Wedgewood Pharmacy: Wedgewood Pharmacy is one of the largest compounding pharmacies in the U.S., specializing in both human and veterinary preparations. It is comparable as a scaled, multi-state compounder with central fulfillment and a national customer base.
• Triangle Compounding Pharmacy: Triangle Compounding Pharmacy is a PCAB-accredited 503A compounding pharmacy offering sterile and non-sterile preparations, including BHRT and hospice formulations. It competes with OptioRx for the same prescriber-driven specialty compounding demand.
• Apothecary by Design (now part of Fagron): Apothecary by Design was a 503A specialty compounding pharmacy serving BHRT, fertility, and integrative medicine markets nationally. It is comparable as a direct specialty-compounding competitor that was acquired by Fagron, illustrating the consolidation pathway OptioRx could follow or face.

Regional players

• Carie Boyd's Prescription Shop (and similar regional compounders): Carie Boyd's is a regional compounding pharmacy serving Oklahoma and surrounding states with BHRT, veterinary, and specialty preparations. It is comparable as a regional compounder that competes with OptioRx for local patient and prescriber relationships.

Others

• PCCA (Professional Compounding Centers of America): PCCA is a leading supplier of APIs, excipients, equipment, and training to independent compounding pharmacies. It is comparable as an upstream ecosystem participant whose products, base formulations, and training many of OptioRx's compounding peers (and OptioRx itself) rely on.

Emerging players

• Amazon Pharmacy: Amazon Pharmacy is an emerging digital-first mail-order pharmacy offering home delivery of prescription medications. It is comparable as a national, technology-enabled mail-order pharmacy that competes with OptioRx's direct-to-home delivery value proposition, though Amazon does not currently offer custom compounding.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/OptioRxPharmacy
• LinkedInlinkedin.com/company/optiorx
• Instagraminstagram.com/optiorx
• Pinterestpinterest.com/optiorx
• Xx.com/OptioRX

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Optio RX